RDF of MGI data
MGIマーカー
transgene insertion 1, Chella David
http://metadb.riken.jp/db/mgi_rdf/MGI:3586631
transgene insertion 1, Chella David(MGIマーカー)
ダウンロード
SPARQL
足あと
問い合わせ
URI表示モード
transgene insertion 1, Chella David
MGIマーカー
MGIマーカー
http://www.w3.org/2000/01/rdf-schema#label
transgene insertion 1, Chella David
シノニム
http://metadb.riken.jp/db/mgi_rdf/Marker_Synonyms
DQ8
HLA-DQ8
Tg(HLA-DQA1*301,HLA-DQB1*302)1Dv
DQ8|HLA-DQ8|Abeta<0>.DQ8|Tg(HLA-DQA1*301,HLA-DQB1*302)1Dv
Abeta<0>.DQ8
シンボル
http://metadb.riken.jp/db/mgi_rdf/Marker_Symbol
Tg(HLA-DQA1,HLA-DQB1)1Dv
MGI Accession ID
http://metadb.riken.jp/db/mgi_rdf/MGI_ID
MGI:3586631
染色体
http://metadb.riken.jp/db/mgi_rdf/MouseChromosome
位置(遺伝的距離)
http://metadb.riken.jp/db/mgi_rdf/cM_Position
genetic mapping procedure
http://metadb.riken.jp/db/mgi_rdf/genetic_mapping_procedure
genome coordinate start
http://metadb.riken.jp/db/mgi_rdf/genome_coordinate_start
genome coordinate end
http://metadb.riken.jp/db/mgi_rdf/genome_coordinate_end
strand
http://metadb.riken.jp/db/mgi_rdf/strand
Status
http://metadb.riken.jp/db/mgi_rdf/Status
O
Marker Type
http://metadb.riken.jp/db/mgi_rdf/Marker_Type
Transgene
Feature Type
http://metadb.riken.jp/db/mgi_rdf/Feature_Type
transgene
See also (jump to original page)
http://www.w3.org/2000/01/rdf-schema#seeAlso
http://identifiers.org/mgd/MGI:3586631
allele
http://metadb.riken.jp/db/mgi_rdf/variant_of
Tg(HLA-DQA1,HLA-DQB1)1Dv
http://metadb.riken.jp/db/mgi_rdf/MGI:3586633
表現型アノテーション
http://metadb.riken.jp/db/mgi_rdf/variant_of
abnormal CD4-positive, alpha beta T cell morphology_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(HLA-DRB1)31Dmz/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0002432I129S2SvPasC57BL6C57BL10SnJCBASJLH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgHLADRB131Dmz0TgIns2CD803B7Flv0TgHLADRB131DmzH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased urine glucose level_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0001759B6CgH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7FlvH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased circulating glucose level_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0005559B6CgH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7FlvH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
salivary gland inflammation_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(HLA-DRB1)31Dmz/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0001870I129S2SvPasC57BL6C57BL10SnJCBASJLH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgHLADRB131Dmz0TgIns2CD803B7Flv0TgHLADRB131DmzH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased urine glucose level_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0001759I129S2SvPasC57BL6C57BL10SnJCBAH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased interferon-gamma secretion_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0008566I129S2SvPasC57BL6C57BL10SnJCBAH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased susceptibility to autoimmune diabetes_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0004803I129S2SvPasC57BL6C57BL10SnJCBAH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
abnormal CD8-positive, alpha beta T cell morphology_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(HLA-DRB1)31Dmz/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0005010I129S2SvPasC57BL6C57BL10SnJCBASJLH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgHLADRB131Dmz0TgIns2CD803B7Flv0TgHLADRB131DmzH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
salivary gland inflammation_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0001870B6CgH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7FlvH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
decreased interleukin-6 secretion_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0008706I129S2SvPasC57BL6C57BL10SnJCBAH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
decreased susceptibility to autoimmune diabetes_Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0004804B6CgTgHLADQA1HLADQB11DvTgIns2CD803B7FlvTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0TgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased circulating glucose level_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0005559I129S2SvPasC57BL6C57BL10SnJCBAH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
decreased susceptibility to autoimmune diabetes_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(HLA-DRB1)31Dmz/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0004804I129S2SvPasC57BL6C57BL10SnJCBASJLH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgHLADRB131Dmz0TgIns2CD803B7Flv0TgHLADRB131DmzH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
increased susceptibility to autoimmune diabetes_H2-Ab1<tm1Gru>/H2-Ab1<tm1Gru>,Tg(HLA-DQA1,HLA-DQB1)1Dv/0,Tg(Ins2-CD80)3B7Flv/0
http://metadb.riken.jp/0004803B6CgH2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7FlvH2Ab1tm1GruH2Ab1tm1GruTgHLADQA1HLADQB11Dv0TgIns2CD803B7Flv0H2Ab1tm1GruTgHLADQA1HLADQB11DvTgIns2CD803B7Flv
class
http://metadb.riken.jp/db/mgi_rdf/variant_of
Tg(HLA-DQA1,HLA-DQB1)1Dv
http://metadb.riken.jp/db/mgi_rdf/MGI:3586633
お問い合わせ
システムのお問い合わせ
画像
足跡